|
시장보고서
상품코드
2050824
유전자 검사 시장 : 유형별, 질환별, 기술별, 지역별Genetic Testing Market, By Type, By Disease, By Technology, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
유전자 검사 시장은 2026년에 291억 7,000만 달러로 추정되고, 2033년에 669억 5,000만 달러에 이를 전망입니다. 또한, 2026-2033년 CAGR 12.6%를 나타낼 것으로 예측됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 291억 7,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 12.60% | 2033년 시장 규모 예측 : | 669억 5,000만 달러 |
유전자 검사는 유전자, 염색체 또는 단백질의 변화를 확인하는 의료 검사의 일종입니다. 유전자 검사 결과는 의심되는 유전성 질환의 유무를 확인하거나 가능성을 배제하는 것은 물론, 개인이 유전성 질환을 앓고 있거나 자손에게 유전할 위험을 판단하는 데 도움이 됩니다. 유전자 검사는 의료의 많은 부분에서 유용하며, 사람들이 받는 의료의 방식을 바꿀 수 있습니다.
시장 역학
유전성 질환 및 희귀질환의 부담 증가, 종양학 부문의 유전자 검사 적용 확대, 유전자 검사 응용 분야 확대, 맞춤형 의료에 대한 높은 수요, 소비자 직접 유전자 검사(DTC)에 대한 수요 증가는 예측 기간 동안 세계 유전자 검사 시장의 성장을 가속할 것으로 예상되는 주요 요인입니다.
예를 들어, 2022년 6월, 유전체 및 진단 검사 분야의 선도 기업 중 하나인 Prenetics Group Limited는 대장암의 조기 징후를 감지하기 위해 획기적인 비침습적 재택 검진 검사 'ColoClear by Circle(ColoClear)'을 발표하였습니다.
또한, 2022년 3월에는 유전체 시퀀싱 기업 Illumina(Illumina)가 하나의 조직 샘플에서 광범위한 종양 유전자를 검사하는 암 검사를 유럽에서 출시하였습니다. 이를 통해 희귀질환을 앓고 있는 환자들이 적절한 치료법을 찾을 수 있는 가능성을 높일 수 있을 것으로 기대됩니다.
본 조사의 주요 특징
- 이 보고서는 다양한 부문의 잠재적 수익 창출 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 보고서는 기업의 주요 특징, 제품 포트폴리오, 주요 특징, 재무 실적, 전략 등의 매개 변수를 기반으로 세계 유전자 검사 시장의 주요 기업 프로파일을 작성했습니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것으로 기대됩니다.
- 세계 유전자 검사 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 유전자 검사 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 유전자 검사 시장 : 유형별, 2022-2033년
제5장 세계의 유전자 검사 시장 : 질환별, 2022-2033년
제6장 세계의 유전자 검사 시장 : 기술별, 2022-2033년
제7장 세계의 유전자 검사 시장 : 지역별, 2022-2033년
제8장 경쟁 구도
제9장 섹션
LSHGenetic Testing Market is estimated to be valued at USD 29.17 Bn in 2026 and is expected to reach USD 66.95 Bn by 2033, growing at a compound annual growth rate (CAGR) of 12.6% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 29.17 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 12.60% | 2033 Value Projection: | USD 66.95 Bn |
Genetic testing is a type of medical test that identifies changes in genes, chromosomes, or proteins. The results of a genetic test can confirm or rule out a suspected genetic condition or help determine a person's chance of developing or passing on a genetic disorder. Genetic testing is useful in many areas of medicine and can change the medical care people receives.
Market Dynamics
Rise in burden of genetic and rare disorders, increasing application of genetic testing in oncology, growing applications of genetic testing, high demand for personalized medicine, and increasing demand for direct-to-consumer genetic testing are major factors expected to augment the growth of the global genetic testing market over the forecast period.
For instance, in June 2022, Prenetics Group Limited, one of the leaders in genomic and diagnostic testing, introduced a novel, non-invasive at-home screening test, ColoClear by Circle (ColoClear), for detecting early signs of colorectal cancer.
Moreover, in March 2022, Illumina, a genome sequencing group, launched a cancer test in Europe that checks for a wide range of tumor genes in one tissue sample, potentially helping patients with rare diseases to be matched up with treatment options.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global genetic testing market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include 23&Me Inc., Qiagen NV, Eurofins Scientific, PerkinElmer Inc., Illumina Inc., Danaher Corporation, Myriad Genetics Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., Quest Diagnostics Incorporated, BioRad Laboratories Inc., and DiaSorin S.p.A. (Luminex Corporation), among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global genetic testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global genetic testing market.
Market Segmentation
- Type Insights (Revenue, USD Bn, 2026 - 2033)
- Carrier Testing
- Diagnostic Testing
- New-born Screening
- Predictive and Presymptomatic Testing
- Prenatal Testing
- Other Types
- Disease Insights (Revenue, USD Bn, 2026 - 2033)
- Alzheimer's Disease
- Cancer
- Cystic Fibrosis
- Sickle Cell Anemia
- Duchenne Muscular Dystrophy
- Thalassemia
- Huntington's Disease
- Rare Diseases
- Other Diseases
- Technology Insights (Revenue, USD Bn, 2026 - 2033)
- Cytogenetic Testing
- Biochemical Testing
- Molecular Testing
- Regional Insights (Revenue, USD Bn, 2026 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
- Key Players Insights
- 23&Me Inc.
- Qiagen NV
- Eurofins Scientific
- PerkinElmer Inc.
- Illumina Inc.
- Danaher Corporation
- Myriad Genetics Inc.
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd.
- Quest Diagnostics Incorporated
- BioRad Laboratories Inc.
- DiaSorin S.p.A. (Luminex Corporation)
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Disease
- Market Snapshot, By Technology
- Market Genetic Testing, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Rise in burden of genetic/rare disorders
- High cost of genetic testing
- Growing applications of genetic testing
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Genetic Testing Market, By Type, 2022-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Carrier Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(USD Bn)
- Diagnostic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(USD Bn)
- New-born Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(USD Bn)
- Predictive and Presymptomatic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(USD Bn)
- Prenatal Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(USD Bn)
- Other Types
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(USD Bn)
5. Global Genetic Testing Market, By Disease, 2022-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Alzheimer's Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(USD Bn)
- Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(USD Bn)
- Cystic Fibrosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(USD Bn)
- Sickle Cell Anemia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(USD Bn)
- Duchenne Muscular Dystrophy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(USD Bn)
- Thalassemia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(USD Bn)
- Huntington's Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(USD Bn)
- Rare Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(USD Bn)
- Other Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(USD Bn)
6. Global Genetic Testing Market, By Technology, 2022-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Cytogenetic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(USD Bn)
- Biochemical Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(USD Bn)
- Molecular Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022-2033,(USD Bn)
7. Global Genetic Testing Market, By Geography, 2022-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2022-2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2022-2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2022-2033,(USD Bn)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2022-2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2022-2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2022-2033,(USD Bn)
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2022-2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2022-2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2022-2033,(USD Bn)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2022-2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2022-2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2022-2033,(USD Bn)
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2022-2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2022-2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2022-2033,(USD Bn)
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2022-2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2022-2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2022-2033,(USD Bn)
8. Competitive Landscape
- 23&Me Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Qiagen NV
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Eurofins Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PerkinElmer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Illumina Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Danaher Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Myriad Genetics Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- F. Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Quest Diagnostics Incorporated
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BioRad Laboratories Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- DiaSorin S.p.A. (Luminex Corporation)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Analyst Views
9. Section
- Research Methodology
- About us
